Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
97 results
  1. Health economics evidence review - Neutropenic Sepsis: Prevention and Management of Neutropenic Sepsis in Cancer ... 
    https://www.ncbi.nlm.nih.gov/books/NBK373682
    ... or secondary prophylaxis with growth factors (for example granulocyte colony stimulating factor) and/or antibiotics (for example fluoroquinolones) Review question ...
  2. List of excluded studies - Diabetic Foot Problems - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK82357
    ... M, Lipsky BA, Mengoli C, de LF. Are granulocyte colony-stimulating factors beneficial in treating diabetic foot infections?: A meta- ... Erle G. Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot ...
  3. Small Cell Lung Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65909
    ... dose every 2 weeks for four cycles with granulocyte colony-stimulating factor (G-CSF) support.[ 34 ] The median dose intensity ... etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung ...
  4. A cost-utility analysis of primary and secondary prophylaxis with G(M)-CSF and/or quinolones for the prevention of ... 
    https://www.ncbi.nlm.nih.gov/books/NBK373675
    ... resistance within the population. Recently, the use of Granulocyte colony-stimulating factor (G-CSF) to prevent neutropenic sepsis has increased ... Organisation for Research and Treatment of Cancer (EORTC). Granulocyte Colony-Stimulating Factor (G-CSF). Guidelines Working Party. EORTC guidelines for ...
  5. 2019New_Mesh_Tree_Hierarchy.txt 
    https://www.nlm.nih.gov/.../download/2019New_Mesh_Tree_Hierarchy.txt
    ... Alfa D12.644.276.374.410.240.350 Granulocyte Colony-Stimulating Factor D12.644.276.374.410.240.350.500 ... 750 Epoetin Alfa D12.776.395.240.200 Granulocyte Colony-Stimulating Factor D12.776.395.240.200.500 Filgrastim D12. ...
  6. pdf2016MeshTree.pdf 
    https://www.nlm.nih.gov/mesh/2016/download/2016MeshTree.pdf
    ... Alfa D12.644.276.374.410.240.350...........................................Granulocyte Colony-Stimulating Factor D12.644.276.374.410.240.350.500........................................... ...
  7. pdf2017MeshTreesWithChangesShown.pdf 
    https://www.nlm.nih.gov/.../2017MeshTreesWithChangesShown.pdf
    ... Growth Factors Colony-Stimulating Factors Erythropoietin Epoetin Alfa Granulocyte Colony-Stimulating Factor Filgrastim Granulocyte-Macrophage Colony-Stimulating Interleukin-3 Macrophage ...
  8. CLPB Deficiency - GeneReviews® - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK396257
    ... per current clinical practice based on the findings. Granulocyte-colony stimulating factor (G-CSF) can be used to increase neutrophil ... ANC) is recommended to determine the need for granulocyte-colony stimulating factor (G-CSF) treatment. Ultrasound examination of the kidneys ...
  9. Epidemiology and service provision of neutropenic sepsis in England and Wales - Neutropenic Sepsis: Prevention and ... 
    https://www.ncbi.nlm.nih.gov/books/NBK373689
    ... is a strategy used to prevent subsequent episodes. Granulocyte colony stimulating factors (GCSF), antibiotics, and alterations to the cytotoxic regimen ...
  10. Management - Non-Hodgkin's Lymphoma: Diagnosis and Management - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK385280
    ... reference costs 2013/14. It was assumed that granulocyte-colony stimulating factor ( GCSF ) would be used in 50% of patients ... of the guideline committee, it was assumed that granulocyte-colony stimulating factor ( GCSF ) would be used in 50% of patients ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last